These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1263 related items for PubMed ID: 31053876
21. Human CD3+CD56+NKT-like cells express a range of complement receptors and C3 activation has negative effects on these cell activity and effector function. Min XY, Liu CF, Cao B, Zhang T, Yang X, Ma N, Wang N, Li K. Hum Immunol; 2021 Sep; 82(9):625-633. PubMed ID: 34134908 [Abstract] [Full Text] [Related]
22. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy. Ayello J, van de Ven C, Cairo E, Hochberg J, Baxi L, Satwani P, Cairo MS. Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292 [Abstract] [Full Text] [Related]
27. NK Cell Subsets Changes in Partial Remission and Early Stages of Pediatric Type 1 Diabetes. Gomez-Muñoz L, Perna-Barrull D, Villalba A, Rodriguez-Fernandez S, Ampudia RM, Teniente-Serra A, Vazquez F, Murillo M, Perez J, Corripio R, Bel J, Vives-Pi M. Front Immunol; 2020 Jun; 11():611522. PubMed ID: 33569058 [Abstract] [Full Text] [Related]
28. Altered Natural Killer Cell Subsets in Seropositive Arthralgia and Early Rheumatoid Arthritis Are Associated with Autoantibody Status. Chalan P, Bijzet J, Kroesen BJ, Boots AM, Brouwer E. J Rheumatol; 2016 Jun; 43(6):1008-16. PubMed ID: 27036380 [Abstract] [Full Text] [Related]
29. Analysis of the Expression of Surface Receptors on NK Cells and NKG2D on Immunocytes in Peripheral Blood of Patients with Nasopharyngeal Carcinoma. Xu Y, Zhou R, Huang C, Zhang M, Li J, Zong J, Qiu S, Lin S, Chen H, Ye Y, Pan J. Asian Pac J Cancer Prev; 2018 Mar 27; 19(3):661-665. PubMed ID: 29580037 [Abstract] [Full Text] [Related]
30. CD3+/CD16+CD56+ cell numbers in peripheral blood are correlated with higher tumor burden in patients with diffuse large B-cell lymphoma. Hus I, Starosławska E, Bojarska-Junak A, Dobrzyńska-Rutkowska A, Surdacka A, Wdowiak P, Wasiak M, Kusz M, Twardosz A, Dmoszyńska A, Roliński J. Folia Histochem Cytobiol; 2011 Mar 27; 49(1):183-7. PubMed ID: 21526506 [Abstract] [Full Text] [Related]
31. Interferon-γ production by tubulointerstitial human CD56bright natural killer cells contributes to renal fibrosis and chronic kidney disease progression. Law BMP, Wilkinson R, Wang X, Kildey K, Lindner M, Rist MJ, Beagley K, Healy H, Kassianos AJ. Kidney Int; 2017 Jul 27; 92(1):79-88. PubMed ID: 28396119 [Abstract] [Full Text] [Related]
32. Higher Frequencies of Lymphocytes Expressing the Natural Killer Group 2D Receptor in Patients With Behçet Disease. Bonacini M, Soriano A, Zerbini A, Calò E, Cimino L, Muratore F, Fontana L, Braglia L, Parmeggiani M, Salvarani C, Croci S. Front Immunol; 2018 Jul 27; 9():2157. PubMed ID: 30319620 [Abstract] [Full Text] [Related]
33. Tissue-resident Eomes(hi) T-bet(lo) CD56(bright) NK cells with reduced proinflammatory potential are enriched in the adult human liver. Harmon C, Robinson MW, Fahey R, Whelan S, Houlihan DD, Geoghegan J, O'Farrelly C. Eur J Immunol; 2016 Sep 27; 46(9):2111-20. PubMed ID: 27485474 [Abstract] [Full Text] [Related]
34. Mass Cytometry Reveals a Sustained Reduction in CD16+ Natural Killer Cells Following Chemotherapy in Colorectal Cancer Patients. Shinko D, McGuire HM, Diakos CI, Pavlakis N, Clarke SJ, Byrne SN, Charles KA. Front Immunol; 2019 Sep 27; 10():2584. PubMed ID: 31749810 [Abstract] [Full Text] [Related]
36. Natural Killer Cells Generated From Human Induced Pluripotent Stem Cells Mature to CD56brightCD16+NKp80+/-In-Vitro and Express KIR2DL2/DL3 and KIR3DL1. Euchner J, Sprissler J, Cathomen T, Fürst D, Schrezenmeier H, Debatin KM, Schwarz K, Felgentreff K. Front Immunol; 2021 Sep 27; 12():640672. PubMed ID: 34017328 [Abstract] [Full Text] [Related]
37. Human NK cells proliferate and die in vivo more rapidly than T cells in healthy young and elderly adults. Lutz CT, Karapetyan A, Al-Attar A, Shelton BJ, Holt KJ, Tucker JH, Presnell SR. J Immunol; 2011 Apr 15; 186(8):4590-8. PubMed ID: 21402893 [Abstract] [Full Text] [Related]
38. Cataloging circulating CD3+CD56+ NKT-like cells through a series of stimulating (NKG2D and DNAM-1) and inhibitory (PD-1, TIGIT, and Tim-3) immune checkpoint receptors in women diagnosed with precancerous cervical lesions or invasive cervical carcinoma. Solorzano-Ibarra F, Alejandre-Gonzalez AG, Ortiz-Lazareno PC, Bueno-Topete MR, Tellez-Bañuelos MC, Haramati J, Del Toro-Arreola S. Immunol Lett; 2024 Oct 15; 269():106889. PubMed ID: 38945372 [Abstract] [Full Text] [Related]
39. CD56+bright and CD56+dim natural killer cells in patients with chronic myelogenous leukemia progressively decrease in number, respond less to stimuli that recruit clonogenic natural killer cells, and exhibit decreased proliferation on a per cell basis. Pierson BA, Miller JS. Blood; 1996 Sep 15; 88(6):2279-87. PubMed ID: 8822949 [Abstract] [Full Text] [Related]
40. Tumor infiltrating NK cell (TINK) subsets and functional molecules in patients with breast cancer. Rezaeifard S, Talei A, Shariat M, Erfani N. Mol Immunol; 2021 Aug 15; 136():161-167. PubMed ID: 34171565 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]